FoxQ1 seemed to crucially regulate NRXN3 expression through direct interaction with NRXN3 promoter, as mutation of FoxQ1 binding sites significantly up-regulated NRXN3 promoter activity in glioma cells. This evidence concerns the gene FOXQ1 and central nervous system cancer.